SDGR Schrödinger, Inc.
Healthcare$13.30+0.53%ClosedMarket Cap: $993.8M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
3.14
P/S
3.90
EV/EBITDA
-9.86
DCF Value
$-47.09
FCF Yield
-14.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.3%
Operating Margin
-64.7%
Net Margin
-40.6%
ROE
-30.8%
ROA
-16.3%
ROIC
-34.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $58.6M | 50.4% | $-48.8M | $-60.0M | $— | — |
| Q4 null | $87.2M | 65.7% | $-17.2M | $32.5M | $— | — |
| FY null | $255.9M | 55.7% | $-166.9M | $-103.3M | $— | — |
| Q3 null | $54.3M | 51.6% | $-45.9M | $-32.8M | $— | — |
| Q2 null | $54.8M | 47.8% | $-52.9M | $-43.2M | $— | — |
| Q1 null | $59.6M | 52.3% | $-50.9M | $-59.8M | $— | — |
| Q4 null | $88.3M | 72.6% | $-20.7M | $-40.2M | $— | — |
| FY null | $207.5M | 63.6% | $-209.3M | $-187.1M | $— | — |
| Q3 null | $35.3M | 50.2% | $-68.4M | $-38.1M | $— | — |
| Q2 null | $47.3M | 66.2% | $-52.7M | $-54.0M | $— | — |
| Q1 null | $36.6M | 51.6% | $-67.4M | $-54.7M | $— | — |
| Q4 2023 | $74.1M | 77.6% | $-29.6M | $-30.7M | $-0.43 | — |